Anti-aging formulation with stabilized Epigallo Catechin Gallate (ECGC)
The present invention provides for an anti-aging formulation comprising an elastomer, dispersant, active such as Epigallo Catechin Gallate (EGCG) and a drug and related methods of manufacture.
1. A formulation consisting of:
at least one elastomer selected from a group consisting of Dimethicone Copolymers in Dimethicone, Vinyldimethicone Copolymers in Dimethicone, Dimethicone crosspolymers in Dimethicone, Vinyldimethicone crosspolymers in Dimethicone, Silicone, and combination and mixtures thereof;
at least one dispersant selected from a group consisting of Cyclomethicone, Isododecane, Hydrocarbons, Esters, Dimethicones, petrolatum, Cyclopentasiloxane, and combination and mixtures thereof;
at least one active selected from a group consisting of Epigallo Catechin Gallate (EGCG);
at least one collagen building active selected from a group consisting of scentella asiatica, peptides, proteins, tissue growth factor (TGF) -Beta, extracts, glucosamine, Resvertrol, Vitamin A, Vitamin B3, Firulic Acid, and combinations and mixtures thereof;
at least one activator selected from a group consisting of Water, Glycerin, Glycols, Polyols, Polyglutamic Acid, Hyaluronic Acid, and combination and mixtures thereof; and
at least one preservative selected from a group consisting of phenoxyethanol, sodium benzoate, sorbic acid, alcohol, carpyl glycol, methylparaben, butyl paraben, propylparaben, ethylparaben, heptylparaben, and combination and mixtures thereof.
2. The formulation of claim 1 wherein said formulation is designed to function as an anti-aging formulation.
3. The formulation of claim 1 wherein said elastomer is from about 5% to about 90% of said formulation.
4. The formulation of claim 1 wherein said dispersant is from about 1% to about 40% of said formulation.
5. The formulation of claim 1 wherein said active is from about 0.1% to about 40% of said formulation.
6. The formulation of claim 1 wherein said activator is from about 1% to about 50% of said formulation.
7. The formulation of claim 1 wherein said preservative is from about 0.1% to about 5% of said formulation.
8. A process for manufacturing a formulation, said process consisting of:
admixing at least one elastomer with at least one dispersant to form a gel, said elastomer is selected from a group consisting of Dimethicone Copolymers in Dimethicone, Vinyldimethicone Copolymers in Dimethicone, Dimethicone crosspolymers in Dimethicone, Vinyldimethicone crosspolymers in Dimethicone, Silicone, and combination and mixtures thereof, said first dispersant is selected from a group consisting of Cyclomethicone, Isododecane, Hydrocarbons, Esters, Dimethicones, petrolatum, Cyclopentasiloxane, and combination and mixtures thereof;
admixing at least one active with said gel to form a delivery system wherein said active in said formulation retains its stability, functionality and aesthetics, said active is Epigallo Catechin Gallate (EGCG);
admixing at least one collagen building active selected from a group consisting of scentella asiatica, peptides, proteins, tissue growth factor (TGF) -Beta, extracts, glucosamine, Resvertrol, Vitamin A, Vitamin B3, Firulic Acid, and combinations and mixtures thereof, to thereby form a formulation with a delivery system;
admixing at least one activator selected from a group consisting of Water, Glycerin, Glycols, Polyols, Polyglutamic Acid, Hyaluronic Acid, and combination and mixtures thereof; and
admixing at least one preservative, said preservatives being selected from a group consisting of phenoxyethanol, sodium benzoate, sorbic acid, alcohol, carpyl glycol, methylparaben, butyl paraben, propylparaben, ethylparaben, heptylparaben, and combination and mixtures thereof.
9. The process of claim 8 wherein said formulation is designed to function as an anti-aging formulation.
10. An anti-aging formulation consisting of:
at least one elastomer selected from a group consisting of Dimethicone Copolymers in Dimethicone, Vinyldimethicone Copolymers in Dimethicone, Dimethicone crosspolymers in Dimethicone, Vinyldimethicone crosspolymers in Dimethicone, Silicone, and combination and mixtures thereof;
at least one dispersant selected from a group consisting of Cyclomethicone, Isododecane, Hydrocarbons, Esters, Dimethicones, petrolatum, Cyclopentasiloxane, and combination and mixtures thereof;
at least one active is Epigallo Catechin Gallate (EGCG);
at least one collagen building active selected from a group consisting of scentella asiatica, peptides, proteins, tissue growth factor (TGF) -Beta, extracts, glucosamine, Resvertrol, Vitamin A, Vitamin B3, Firulic Acid, and combinations and mixtures thereof;
at least one activator selected from a group consisting of Water, Glycerin, Glycols, Polyols, Polyglutamic Acid, Hyaluronic Acid, and combination and mixtures thereof; and
at least one preservative being selected from a group consisting of phenoxyethanol, sodium benzoate, sorbic acid, alcohol, carpyl glycol, methylparaben, butyl paraben, propylparaben, ethylparaben, heptylparaben, and combination and mixtures thereof, said formulation is designed to treat anti-aging.
11. A method of manufacturing a formulation, said process consisting of:
admixing at least one elastomer with at least one dispersant to form a gel, said elastomer is selected from a group consisting of Dimethicone Copolymers in Dimethicone, Vinyldimethicone Copolymers in Dimethicone, Dimethicone crosspolymers in Dimethicone, Vinyldimethicone crosspolymers in Dimethicone, Silicone, and combination and mixtures thereof, said first dispersant is selected from a group consisting of Cyclomethicone, Isododecane, Hydrocarbons, Esters, Dimethicones, petrolatum, Cyclopentasiloxane, and combination and mixtures thereof;
admixing at least one active with said gel to form a delivery system wherein said active in said formulation retains its stability, functionality and aesthetics, said active is Epigallo Catechin Gallate (EGCG); and
admixing at least one collagen building active selected from a group consisting of scentella asiatica, peptides, proteins and tissue growth factor (TGF) -Beta, natural extracts, glucosamine, Resvertrol, Vitamin A, Vitamin B3, Firulic Acid, and combinations and mixtures thereof to thereby form a formulation with a delivery system.
12. The method of claim 11 wherein said formulation is designed to be an anti-aging formulation.